Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-525-2 | CAS number: 96-69-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- unknown
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: A maximisation test was performed based on the current test guidelines but GLP and test guideline are not mentioned
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: no guideline mentioned
- Deviations:
- no
- Principles of method if other than guideline:
- The testing was conducted in accordance with the Nakamura et al. improved method (1994) for the Magnusson and Kligman GPMT (1996). This method consists of sensitization exposure using intradermal injection and epicutaneous application, along with challenge exposure to challenge an immunological response (onset of erythema or edema) in the treatment site through reapplication after a certain period of time
- GLP compliance:
- not specified
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Historical study available before LLNA method was developed.
Test material
- Details on test material:
- 4,4′-thio-bis(3-methyl-6-tert-butylphenol)
(TBMBP: CAS No. 96-69-5, Nocrac 300 (manufactured by Ouchi Shinko Chemical Industrial))
Purity: Unknown.
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- Five-week old Std:Hartley strain female guinea pigs (clean) were purchased from Japan SLC, Inc. for the GPMT, and were used for the test after one week of acclimatization. Animals that had no abnormalities in general status or the skin at the administration site on the day before administration were selected and divided randomly into groups. The guinea pigs were freely given solid feed RC-4 (manufactured by Oriental KK) and tap water during both the acclimatization period and the test period. They were kept in an animal room at a temperature of 23 ± 2°C with lights on from 7:00 AM to 7:00 PM
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- olive oil
- Concentration / amount:
- Multiple concentrations were tested, the most relevant for interpretation:
Intradermal: 0 (control), 0.5% (experimental)
epidermal induction: 0 (control), 25% (experimental)
Challenge: 0 and 5%
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- olive oil
- Concentration / amount:
- Multiple concentrations were tested, the most relevant for interpretation:
Intradermal: 0 (control), 0.5% (experimental)
epidermal induction: 0 (control), 25% (experimental)
Challenge: 0 and 5%
- No. of animals per dose:
- 10 experimentals and 5 controls per group
- Details on study design:
- A skin irritation study was carried out for each test substance (intradermal administration, sealed patch, open application), the maximum concentrations that could be used in each process were determined, and a preliminary test of skin sensitization was performed.
The following groups were established: A group for which the maximum dosage that could be applied was used for primary sensitization and secondary sensitization (high dosage group), a group for which 1/10,000 of the primary sensitization concentration used for the high dose group was used for primary and secondary sensitization (low dosage group), and, in order to study whether or not skin sensitization was established by the sec-ondary sensitization procedure only, a group for which the first sensitization concentration was set at 0% (solvent administered) and the secondary sensitization concentration was set at the concentration used in the high dose group (sealed patch group), and a control group. The number of animals used in each group was five. In the results of this test, positive reactions were observed for TBMBP in the high dosage group.
Based on the results of the test described above, the dose responsiveness of TBMBP was studied, which was conjectured to have skin sensitization. The dosages, challenge concentrations (open application), and numbers of animals used in the tests are indicated above. A non-sensitization group, which was administered the solvents for each test substance in the skin sensitization test, was provided.
Emulsified solutions of TMCBDPB and HMBCDPB were prepared at the time of use during primary sensitization by taking a Pharmacopoeia olive oil solution or suspension at the prescribed concentrations and by dissolving or suspending these test substances in FCA such that the concentration wouldbe 2 times higher, after which the material was mixed with the equivalent amount of physiological saline solution. Since there was moderate skin irritation for all of the test substances, it was alleviated by treatment with 10% sodium lauryl sulfate (SLS) Vaseline ointment. The evaluation of the skin reaction was determined forty-eight and seventy-two hours after the challenge exposure. - Challenge controls:
- yes
- Positive control substance(s):
- yes
- Remarks:
- DNCB
Results and discussion
- Positive control results:
- The DNCB positive control revealed positive results:
A skin sensitization test of DNCB, which was the positive control substance, was performed in parallel. The mean evaluation points after forty-eight hours of challenge were 0.8 for challenge concentrations of 10 ppm, 4.0 for 100 ppm, and 5.2 for 1,000 ppm. These results confirmed that favorable skin sensitization reactions were shown to the positive control substance in the lot of guinea pigs used in these tests.
The sensitization rate was not specified in this report.
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 5%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 5%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 5%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 5%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5%
- No. with + reactions:
- 7
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 5%. No with. + reactions: 7.0. Total no. in groups: 10.0. Clinical observations: none.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 5%
- No. with + reactions:
- 7
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 5%. No with. + reactions: 7.0. Total no. in groups: 10.0. Clinical observations: none.
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- The relative challenge strength of TBMPM as found based on the dose responsiveness of skin reaction (mean evaluation points) and challenge concentration in the 0.5% sensitization group was calculated to be 0.9. DNCB, which was used as a positive control, is a compound representative of skin sensitizing substances, but its relative challenge strength was calculated to be 13.0. It is considered that, when these values are compared, TBMBP is a more weakly sensitizing substance than DNCB.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.